Pharmacodynamic activity of ertapenem versus genotypically characterized extended-spectrum -lactamase (ESBL)-, KPC- or NDM-producing Escherichia coli with reduced susceptibility or resistance to ertapenem using an in vitro model
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.